Tonix Pharmaceuticals Holding Corp
TNXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$196.55M
Close$
$12.37
8.5% upside
Current Fair Value
8.5% upsideUndervalued by 8.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $196.55 Million |
|---|---|
| Enterprise Value | $12.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.57 |
| Beta | 1.69 |
| Outstanding Shares | 13,707,104 |
Return
| Return on Equity | -31.79% |
|---|---|
| Return on Assets | -28.00% |
| Return on Invested Capital | -65.77% |
Valuation & Multiples
| P/E Ratio | -1.15 |
|---|---|
| PEG | - |
| Price to Sales | 11.4 |
| Price to Book Ratio | 0.71 |
| Enterprise Value to Revenue | 0.7 |
| Enterprise Value to EBIT | -0.08 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-2.54
Average shareholder expectationRevenue Estimate
$6.13 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-2.55
Average shareholder expectationRevenue Estimate
$7.85 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7566▼ 107.30% |
|---|---|
| Total Calls | 154,500▲ 213.39% |
| Total Puts | 116,900▲ 29.60% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 57.21%▲ 15.26% |
|---|---|
| Total Invested | $66.97M▲ 14.50% |
| Investors Holding | 87▲ 12.00% |
ESG Score
No data
About Tonix Pharmaceuticals Holding Corp
CEO: Seth Lederman